|
1.
|
Schuppan D, Krebs A, Bauer M and Hahn EG:
Hepatitis C and liver fibrosis. Cell Death Differ. 10(Suppl 1):
S59–S67. 2003. View Article : Google Scholar
|
|
2.
|
Gressner OA, Rizk MS, Kovalenko E,
Weiskirchen R and Gressner AM: Changing the pathogenetic roadmap of
liver fibrosis? Where did it start; where will it go? J
Gastroenterol Hepatol. 23:1024–1035. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Kong X, Horiguchi N, Mori M and Gao B:
Cytokines and STATs in liver fibrosis. Front Physiol. 3:692012.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Friedman SL: Mechanisms of hepatic
fibrogenesis. Gastroenterology. 134:1655–1669. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Vettori S, Gay S and Distler O: Role of
microRNAs in fibrosis. Open Rheumatol J. 6:130–139. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Berezikov E, Guryev V, van de Belt J,
Wienholds E, Plasterk RH and Cuppen E: Phylogenetic shadowing and
computational identification of human microRNA genes. Cell.
120:21–24. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Kozomara A and Griffiths-Jones S: miRBase:
integrating microRNA annotation and deep-sequencing data. Nucleic
Acids Res. 39:D152–D157. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Brennecke J, Hipfner DR, Stark A, Russell
RB and Cohen SM: bantam encodes a developmentally regulated
microRNA that controls cell proliferation and regulates the
proapoptotic gene hid in Drosophila. Cell. 113:25–36. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Schratt GM, Tuebing F, Nigh EA, et al: A
brain-specific microRNA regulates dendritic spine development.
Nature. 439:283–289. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Chen CZ, Li L, Lodish HF and Bartel DP:
MicroRNAs modulate hematopoietic lineage differentiation. Science.
303:83–86. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Mott JL, Kobayashi S, Bronk SF and Gores
GJ: mir-29 regulates Mcl-1 protein expression and apoptosis.
Oncogene. 26:6133–6140. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Chen L, Jiang M, Yuan W and Tang H:
miR-17-5p as a novel prognostic marker for hepatocellular
carcinoma. J Invest Surg. 25:156–161. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Yang F, Yin Y, Wang F, et al: miR-17-5p
promotes migration of human hepatocellular carcinoma cells through
the p38 mitogen-activated protein kinase-heat shock protein 27
pathway. Hepatology. 51:1614–1623. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Venugopal SK, Jiang J, Kim TH, et al:
Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in
hepatic stellate cells, and their overexpression causes decreased
stellate cell activation. Am J Physiol Gastrointest Liver Physiol.
298:G101–G106. 2010. View Article : Google Scholar
|
|
16.
|
Ji J, Zhang J, Huang G, Qian J, Wang X and
Mei S: Over-expressed microRNA-27a and 27b influence fat
accumulation and cell proliferation during rat hepatic stellate
cell activation. FEBS Lett. 583:759–766. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Iizuka M, Ogawa T, Enomoto M, et al:
Induction of microRNA-214-5p in human and rodent liver fibrosis.
Fibrogenesis Tissue Repair. 5:122012. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Thompson WJ, Piazza GA, Li H, et al:
Exisulind induction of apoptosis involves guanosine 3′,5′-cyclic
monophosphate phosphodiesterase inhibition, protein kinase G
activation, and attenuated beta-catenin. Cancer Res. 60:3338–3342.
2000.PubMed/NCBI
|
|
20.
|
Gressner AM, Weiskirchen R, Breitkopf K
and Dooley S: Roles of TGF-beta in hepatic fibrosis. Front Biosci.
7:d793–d807. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Sysa P, Potter JJ, Liu X and Mezey E:
Transforming growth factor-beta1 up-regulation of human alpha(1)(I)
collagen is mediated by Sp1 and Smad2 transacting factors. DNA Cell
Biol. 28:425–434. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Bataller R and Brenner DA: Hepatic
stellate cells as a target for the treatment of liver fibrosis.
Semin Liver Dis. 21:437–451. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Friedman SL: Molecular regulation of
hepatic fibrosis, an integrated cellular response to tissue injury.
J Biol Chem. 275:2247–2250. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Wu J and Zern MA: Hepatic stellate cells:
a target for the treatment of liver fibrosis. J Gastroenterol.
35:665–672. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Kwiecinski M, Noetel A, Elfimova N, et al:
Hepatocyte growth factor (HGF) inhibits collagen I and IV synthesis
in hepatic stellate cells by miRNA-29 induction. PLoS One.
6:e245682011. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Gressner AM and Weiskirchen R: Modern
pathogenetic concepts of liver fibrosis suggest stellate cells and
TGF-beta as major players and therapeutic targets. J Cell Mol Med.
10:76–99. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Geerts A, Schuppan D, Lazeroms S, De
Zanger R and Wisse E: Collagen type I and III occur together in
hybrid fibrils in the space of Disse of normal rat liver.
Hepatology. 12:233–241. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Milani S, Herbst H, Schuppan D, Surrenti
C, Riecken EO and Stein H: Cellular localization of type I III and
IV procollagen gene transcripts in normal and fibrotic human liver.
Am J Pathol. 137:59–70. 1990.PubMed/NCBI
|
|
29.
|
Sekiya Y, Ogawa T, Yoshizato K, Ikeda K
and Kawada N: Suppression of hepatic stellate cell activation by
microRNA-29b. Biochem Biophys Res Commun. 412:74–79. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Ogawa T, Iizuka M, Sekiya Y, Yoshizato K,
Ikeda K and Kawada N: Suppression of type I collagen production by
microRNA-29b in cultured human stellate cells. Biochem Biophys Res
Commun. 391:316–321. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Xu L, Hui AY, Albanis E, et al: Human
hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis
of hepatic fibrosis. Gut. 54:142–151. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Kitada T, Seki S, Nakatani K, Kawada N,
Kuroki T and Monna T: Hepatic expression of c-Myb in chronic human
liver disease. Hepatology. 26:1506–1512. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Lee KS, Buck M, Houglum K and Chojkier M:
Activation of hepatic stellate cells by TGF alpha and collagen type
I is mediated by oxidative stress through c-myb expression. J Clin
Invest. 96:2461–2468. 1995. View Article : Google Scholar : PubMed/NCBI
|
